AlzBiomarker
Parkinson's Disease Dementia vs Alzheimer's Disease: tau-p181 (CSF)
Meta-analysis showed that levels of tau-p181 in the cerebrospinal fluid of people with Parkinson's disease dementia are approximately half those of people with people with Alzheimer's disease (effect size = 0.527, p <0.0001). For comparison, the level of CSF tau-p181 in control subjects is also about half that of AD patients.
Loading data...